Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 DISEASE NETWORK REGISTRY PROJECTS LOGIN
 
 
  
U.K. - UKHDN - Activities -
--->News
[+]The Project
[-]Locations
--->[+]Austria
--->[+]Belgium
--->[+]Czech Republic
--->[+]Denmark
--->[+]Finland
--->[+]France
--->[+]Germany
--->[+]Ireland
--->[+]Italy
--->[+]Netherlands
--->[+]Norway
--->[+]Poland
--->[+]Portugal
--->[+]Russia
--->[+]Spain
--->[+]Sweden
--->[+]Switzerland
--->[-]U.K.
--->Coordination
--->HD Associations
--->Links
--->[-]UKHDN
--->Member Sites
--->Activities
--->News
--->Meetings
--->Research prog
--->Documents
--->Standard of Care
--->Aberdeen
--->[+]Ayr
--->Belfast
--->Birmingham
--->[+]Blandford Forum
--->Bristol
--->Cambridge
--->Cardiff
--->Dundee
--->Edinburgh
--->Exeter
--->Fife
--->Forth Valley
--->Glasgow
--->Gloucester
--->Hull
--->Inverness
--->Launceston
--->Leeds
--->Leicester
--->Liverpool
--->London - Guy's Hospital
--->London - Hammersmith
--->London - NHNN
--->London - Royal Hospital
--->London - St. George´s
--->Manchester
--->Newcastle-Upon-Tyne
--->[+]Northampton
--->Nottingham
--->Oxford
--->[+]Plymouth
--->Poole
--->Preston
--->Reading
--->[+]Sheffield
--->Southampton
--->Stoke-on-Trent
--->Swindon
--->Wrexham
--->[+]Outside Europe
[-]Working Groups
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[-]Imaging
--->[+]Dates
--->[+]Meetings
--->[+]Juvenile HD
--->[+]Motor Phenotype
--->[+]Neuroprotective Therapy
--->[+]Physiotherapy
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[+]Symptomatic Research
--->[+]Young Adults
[-]Events
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[+]EHDN 2012
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[+]Communication
--->Job Offers

Activities of the UK Huntington's disease Network

  • The UK Huntington's disease Network (UKHDN) works in tandem with other clinical HD networks – members are involved in the Network of European CNS Transplantation And Restoration (NECTAR) which includes over 40 groups of clinicians and basic scientists. NEST-HD is a subgroup of NECTAR devoted to transplantation in Huntington's disease.  Four UKHDN sites are also active members of the NEST-UK trial.  The UKHDN are one of the founder groups of the European Huntington’s disease Network.
  • The UKHDN supports national and European research initiatives in collaboration with EHDN.  
  • The UKHDN hosts forums for discussion of relevant scientific findings and mediates the development and review of ethical considerations surrounding research and clinical management of HD. Members of the Network serve in an advisory and training capacity to clinicians wishing to implement the Unified Huntington’s disease Rating Scale (UHDRS) and have facilitated the implementation of NHS HD Management Clinics in geographical areas with no pre-existing service.
  
about us | privacy statement | disclaimer | terms of use